In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss
Science Advances · 2024
DOI: 10.1126/sciadv.adk2299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Sarath Vijayakumar und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Medicine, Creighton University, Omaha, NE 68178, USA. Hauptthemen laut MEDLINE: ErbB Receptors, Zebrafish, Transcriptome, Hearing Loss, Noise-Induced. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDCD NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Noise-induced hearing loss (NIHL) is a common sensorineural hearing impairment that lacks U.S. Food and Drug Administration–approved drugs. To fill the gap in effective screening models, we used an in silico transcriptome-based drug screening approach, identifying 22 biological pathways and 64 potential small molecule treatments for NIHL. Two of these, afatinib and zorifertinib [epidermal growth factor receptor (EGFR) inhibitors], showed efficacy in zebrafish and mouse models. Further tests with EGFR knockout mice and EGF-morpholino zebrafish confirmed their protective role against NIHL. Molecular studies in mice highlighted EGFR’s crucial involvement in NIHL and the protective effect of zorifertinib. When given orally, zorifertinib was found in the perilymph with favorable pharmacokinetics. In addition, zorifertinib combined with AZD5438 (a cyclin-dependent kinase 2 inhibitor) synergistically prevented NIHL in zebrafish. Our results underscore the potential for in silico transcriptome-based drug screening in diseases lacking efficient models and suggest EGFR inhibitors as potential treatments for NIHL, meriting clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, School of Medicine, Creighton University, Omaha, NE 68178, USA.
- Department of Neurosciences, University of Toledo, Toledo, OH 43614, USA.
- Neurosciences Institute, ProMedica, Toledo, OH 43606, USA.
- Ting Therapeutics, 9310 Athena Circle, San Diego, CA 92037, USA.
ORCID-Profile: Sarath Vijayakumar, Joseph A DiGuiseppi, Parinaz Jila Dabestani, William G Ryan, Rene Vielman Quevedo, Jonathan Fleegel, Ali Sajid Imami, Abdul-Rizaq Ali Hamoud, Sándor Lovas, Robert E McCullumsmith, Marisa Zallocchi, Jian Zuo
Förderung
- NIA NIH HHS
- NIDCD NIH HHS
- NIMH NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Vijayakumar, S., DiGuiseppi, J. A., Dabestani, P. J., Ryan, W. G., Quevedo, R. V., Li, Y., Diers, J., Tu, S., Fleegel, J., Nguyen, C., Rhoda, L. M., Imami, A. S., Hamoud, A. A., Lovas, S., McCullumsmith, R. E., Zallocchi, M., & Zuo, J. (2024). In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss. Science Advances. https://doi.org/10.1126/sciadv.adk2299
Vancouver
Vijayakumar S, DiGuiseppi JA, Dabestani PJ, Ryan WG, Quevedo RV, Li Y, et al. In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss. Science Advances. 2024. doi:10.1126/sciadv.adk2299
BibTeX
@article{Vijayakumar2024,
author = {Vijayakumar, Sarath and DiGuiseppi, Joseph A and Dabestani, Parinaz Jila and Ryan, William G and Quevedo, Rene Vielman and Li, Yuju and Diers, Jack and Tu, Shu and Fleegel, Jonathan and Nguyen, Cassidy and Rhoda, Lauren M and Imami, Ali Sajid and Hamoud, Abdul-Rizaq Ali and Lovas, Sándor and McCullumsmith, Robert E and Zallocchi, Marisa and Zuo, Jian},
title = {In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adk2299}
}
EUVIMED